December 6, 2017 / 12:22 PM / in 5 days

BRIEF-Nanoviricides Initiates a Safety/Toxicology Study of Its Leading Shingles Candidates

Dec 6 (Reuters) - Nanoviricides Inc:

* NANOVIRICIDES - BEGUN INITIAL SAFETY, TOXICOLOGY EVALUATION OF CO‘S NANOVIRICIDES DRUG CANDIDATES DEVELOPED AGAINST THE SHINGLES VIRUS VARICELLA-ZOSTER Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below